Adherence to medication, particularly for chronic illness, has traditionally been poor, occurring only about 50% of the time. Given that the prevalence of chronic illness has never been higher, the potential effects of non-adherence are vast. Non-adherence is thought to be the cause of over 300,000 deaths in Europe and America, while costing over €300 billion, annually. Thus interventions aimed at reducing non-adherence are of critical importance.
From a behavioural perspective, common predictors of non-adherence include procrastination, forgetfulness, side effects, the challenge of managing multiple prescriptions, misunderstanding disease, imperfect drug regimens, cognitive impairments, and a reduced sense of urgency due to asymptomatic conditions. Adherence decreases as the complexity, cost, and duration of the regimen increases.
Technology via eHealth has a potentially significant role in addressing some of these behavioural issues. This White Paper focuses on some eHealth behavioural intervention-types, and provides some recommendations of ways to develop such interventions.
Dr. Daniel Regan (ARCH)
27th July 2016
Read the Full White Paper: Medication Adherence-Improvements via eHealth Behaviour Change Interventions